Novel compounds

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/62 (2006.01) A61K 38/19 (2006.01) A61K 39/395 (2006.01) C07K 14/54 (2006.01) C07K 16/00 (2006.01) C07K 19/00 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2196200

A soluble protein having IL4 and/or IL13 antagonist or partial antagonist activity comprises an IL4 mutant or variant fused to at least one human immunoglobulin constant domain or fragment thereof.

Protéine soluble ayant une activité antagoniste complète ou partielle de IL4 (interleukine 4) et/ou de IL13, qui comprend un variant ou mutant de IL4 fusionné avec au moins un domaine constant d'immunoglobuline humaine ou fragment dudit domaine.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1571588

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.